| Dr Qiyuan Dai, MD | |
|
45104 10th St W, Lancaster, CA 93534-2310 | |
| (661) 942-2391 | |
| (661) 942-2391 |
| Full Name | Dr Qiyuan Dai |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 45104 10th St W, Lancaster, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043506728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A127877 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Two studies presented at the ANESTHESIOLOGY 2012 annual meeting found that hereditary genes were responsible for the amount and type of pain experienced after a motor vehicle collision (MVC).
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system completed a pharmacokinetic (PK) study of the first formulation of its lead drug, TNX-102, for the treatment of fibromyalgia syndrome.
Heart disease and heart-related illnesses are a leading cause of death around the world, but treatment options are limited. Now, one group reports in ACS Nano that encapsulating stem cells in a nanogel could help repair damage to the heart.
Results of a randomised trial from Uganda in this week's issue of THE LANCET suggest that the drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria in terms of efficacy and cost-effectiveness in this region.
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
› Verified 9 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Two studies presented at the ANESTHESIOLOGY 2012 annual meeting found that hereditary genes were responsible for the amount and type of pain experienced after a motor vehicle collision (MVC).
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system completed a pharmacokinetic (PK) study of the first formulation of its lead drug, TNX-102, for the treatment of fibromyalgia syndrome.
Heart disease and heart-related illnesses are a leading cause of death around the world, but treatment options are limited. Now, one group reports in ACS Nano that encapsulating stem cells in a nanogel could help repair damage to the heart.
Results of a randomised trial from Uganda in this week's issue of THE LANCET suggest that the drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria in terms of efficacy and cost-effectiveness in this region.
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Qiyuan Dai, MD 45104 10th St W, Lancaster, CA 93534-2310 Ph: (661) 942-2391 | Dr Qiyuan Dai, MD 45104 10th St W, Lancaster, CA 93534-2310 Ph: (661) 942-2391 |
News Archive
Two studies presented at the ANESTHESIOLOGY 2012 annual meeting found that hereditary genes were responsible for the amount and type of pain experienced after a motor vehicle collision (MVC).
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system completed a pharmacokinetic (PK) study of the first formulation of its lead drug, TNX-102, for the treatment of fibromyalgia syndrome.
Heart disease and heart-related illnesses are a leading cause of death around the world, but treatment options are limited. Now, one group reports in ACS Nano that encapsulating stem cells in a nanogel could help repair damage to the heart.
Results of a randomised trial from Uganda in this week's issue of THE LANCET suggest that the drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria in terms of efficacy and cost-effectiveness in this region.
Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.
› Verified 9 days ago
Dr. Tanyanika Phillips, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44151 15th St W Ste 101, Lancaster, CA 93534 Phone: 661-902-5600 Fax: 661-951-0686 | |
Dr. Violeta Vallejo-sinavsky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44900 60th St W, Lancaster, CA 93536 Phone: 661-948-8581 Fax: 661-945-8474 | |
Justin Chang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 43112 15th St W, Lancaster, CA 93534 Phone: 626-380-5527 | |
Karandeep Singh, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 45104 10th St W, Lancaster, CA 93534 Phone: 562-867-7999 | |
Zin Win, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 43112 15th St W, Lancaster, CA 93534 Phone: 661-726-2245 | |
Pye Aung, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 W Avenue J, Lancaster, CA 93534 Phone: 661-726-6254 |